Journal metric profile

THERAPEUTIC DRUG MONITORING

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 2.400 2025 metric year
5-Year Impact Factor 2.700 Longer citation window
JCR Quartile Q2 Subject-category quartile
JCR Category Rank 14/33 Recorded category rank

THERAPEUTIC DRUG MONITORING JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

THERAPEUTIC DRUG MONITORING metric snapshot

THERAPEUTIC DRUG MONITORING has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is LIPPINCOTT WILLIAMS & WILKINS. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 2.400. The five-year Journal Impact Factor is 2.700, giving a second citation window for comparison. The journal is recorded in quartile Q2 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 14 out of 33 journals. Based on that rank position, the journal sits within approximately the top 42% of the listed category. Its listed quartile is Q2. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.700) is 0.300 points higher than the standard Journal Impact Factor (2.400). Without journal self-citations, the Impact Factor is 2.200, a difference of 0.200 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.740. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for THERAPEUTIC DRUG MONITORING lists total cites: 4,307; total articles: 92; citable items: 104. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 10 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 7.6 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

THERAPEUTIC DRUG MONITORING is identified in this directory by print ISSN 0163-4356 and electronic ISSN 1536-3694. The publisher is recorded as LIPPINCOTT WILLIAMS & WILKINS. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameTHERAPEUTIC DRUG MONITORING
Abbreviated journalTHER DRUG MONIT
PublisherLIPPINCOTT WILLIAMS & WILKINS
Metric year2025
Overall rank6,685
ISSN0163-4356
eISSN1536-3694
Total cites4,307
Total articles92
Citable items104
Cited half-life10 years
Citing half-life7.6 years
JCR-based Journal Impact Factor2.400
5-Year Impact Factor2.700
Impact Factor without journal self-cites2.200
Journal Citation Indicator0.740
JCR Impact Factor quartileQ2
JCR category rank14/33
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of THERAPEUTIC DRUG MONITORING?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for THERAPEUTIC DRUG MONITORING is 2.400 for the 2025 metric year.

What are the JCR quartile and category rank of THERAPEUTIC DRUG MONITORING?

THERAPEUTIC DRUG MONITORING is listed with quartile Q2 and category rank 14/33. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of THERAPEUTIC DRUG MONITORING?

The five-year Journal Impact Factor recorded for THERAPEUTIC DRUG MONITORING is 2.700. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes THERAPEUTIC DRUG MONITORING?

THERAPEUTIC DRUG MONITORING is listed in this directory as being published by LIPPINCOTT WILLIAMS & WILKINS.

Additional records from the same publisher or with a similar listed JCR Impact Factor.